Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-15-005813
Filing Date
2015-06-26
Accepted
2015-06-26 16:36:16
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 a2224901zs-3.htm S-3 425697
2 EX-1.2 a2224901zex-1_2.htm EX-1.2 302377
3 EX-4.3 a2224901zex-4_3.htm EX-4.3 322850
4 EX-4.4 a2224901zex-4_4.htm EX-4.4 712655
5 EX-5.1 a2224901zex-5_1.htm EX-5.1 55839
6 EX-5.2 a2224901zex-5_2.htm EX-5.2 27348
7 EX-12.1 a2224901zex-12_1.htm EX-12.1 45257
8 EX-23.1 a2224901zex-23_1.htm EX-23.1 3364
9 G446477.JPG g446477.jpg GRAPHIC 19756
10 G343099.JPG g343099.jpg GRAPHIC 11983
11 G104358.JPG g104358.jpg GRAPHIC 17471
  Complete submission text file 0001047469-15-005813.txt   1968112
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205275 | Film No.: 15955566
SIC: 2834 Pharmaceutical Preparations

Mailing Address ARTHUR COX BUILDING, EARLSFORT TERRACE DUBLIN 2 L2 00000
Business Address ARTHUR COX BUILDING, EARLSFORT TERRACE DUBLIN 2 L2 00000 6508086000
Theravance Biopharma Ireland Ltd (Filer) CIK: 0001645834 (see all company filings)

EIN.: 981244252 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205275-04 | Film No.: 15955570

Mailing Address 90 FETTER LANE LONDON X0 EC4A 1EQ
Business Address 90 FETTER LANE LONDON X0 EC4A 1EQ 6508086000
Theravance Biopharma UK Ltd (Filer) CIK: 0001645844 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205275-02 | Film No.: 15955568

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN E9 KY1-1104 6508086000
Theravance Biopharma Cayman Holdings, Inc. (Filer) CIK: 0001645881 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205275-05 | Film No.: 15955571

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN E9 KY1-1104 6508086000
Theravance Biopharma R&D, Inc. (Filer) CIK: 0001645883 (see all company filings)

EIN.: 981226606 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205275-03 | Film No.: 15955569

Mailing Address 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 6508086000
Theravance Biopharma US, Inc. (Filer) CIK: 0001645884 (see all company filings)

EIN.: 463451245 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205275-01 | Film No.: 15955567

Mailing Address UGLAND HOUSE SOUTH CHURCH STREET GEORGE TOWN E9 KY1-1104
Business Address UGLAND HOUSE SOUTH CHURCH STREET GEORGE TOWN E9 KY1-1104 650-808-6000
Theravance Biopharma Antibiotics, Inc. (Filer) CIK: 0001646102 (see all company filings)

EIN.: 981136083 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205275-06 | Film No.: 15955572